ID: MRFR/Pharma/2938-HCR | February 2021 | Region: Global | 200 pages
Market Synopsis of the Global Antidiuretic drugs Market
Antidiuretic substance helps to control the fluid balance in the body. Their action is opposite to that of diuretics which disrupt this balance. Major antidiuretic drugs are vasopressin (also known as antidiuretic hormone (ADH)), desmopressin, and oxytocin. In diabetes insipidus, antidiuretic drugs reduce the urine volume. Desmopressin is widely used antidiuretic drug as it is relatively inexpensive and safe having minimum adverse reactions to the body. It is primarily used for treating patients with hemophilia.
Rising prevalence of diabetes and other chronic disease such as cardiovascular diseases, growing use of antidiuretic drugs for the treatment of hemophilia and huge patient pool with hypertension, drives the growth of antidiuretic drugs markets.
The global antidiuretic drugs market is expected to grow at a CAGR of 9.7% during the forecast period and is estimated to reach USD 180 million by 2023.
FIGURE 1 Global Antidiuretic Drugs Market by region, 2016 (%)
Key Players in the Global Antidiuretic drugs Market
Some of the key players in this market are Par Sterile Products, LLC (U.S.), ADH Health (U.S.), Azevan Pharmaceuticals, Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Otsuka Holdings Co. Ltd (Japan), Taj Pharmaceuticals Limited (India) and ALLERGAN (U.S.).
The global antidiuretic drugs market is segmented on the basis of types, which includes vasopressin, desmopressin, oxytocin, and others. Other types of antidiuretic drugs are argipressin, lypressin, ornipressin and terlipressin. On the basis of indication, the market is segmented into diabetes insipidus, hemophilia, hypertension, and others. Diabetes insipidus is further sub-segmented into central diabetes insipidus, nephrogenic diabetes insipidus, dipsogenic diabetes insipidus and gestational diabetes insipidus. Other indications are polyuria, polydipsia and enuresis. On the basis of end users, the market is segmented into hospitals, clinics, pharmaceutical companies, and others.
Regional Analysis of the Global Antidiuretic drugs Market
The American region accounted for the largest share of the global market due to increasing prevalence of diabetes insipidus, and rising demand for new drugs for the treatment of diabetes insipidus. The rate of diabetes insipidus is much higher in America than the rest of the world. According to the Diabetes Insipidus Organization, in the U.S., 1 in 6,666 American may develop diabetes insipidus. According to International Diabetes Federation, in 2016, it was estimated that 420 million adult population was suffering from diabetes which is increasing at the rate of 8.4% and is expected to reach 625 million by 2040.
Europe is the second largest market that holds a noticeable share of the global antidiuretic drugs market. Diabetes insipidus is a common postoperative complication among children who have undergone transsphenoidal craniotomy.
In Asia Pacific, rising awareness about diabetes insipidus, huge geriatric population suffering from diabetes insipidus and increase in the risk of developing diabetes insipidus after surgery is driving the market growth. Furthermore, rising awareness about the use of antidiuretic drugs for the treatment of diabetes insipidus also propels the market growth.
Middle East and Africa show steady growth in the antidiuretic drugs market.
The report on the global antidiuretic drugs market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain deeper insight to the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions
Frequently Asked Questions (FAQ) :
The predicted CAGR is 9.7% for the forecast period of 2017-2023.
Antidiuretic Drugs Market valuation would be USD 180 million by 2023.
The companies are ADH Health (U.S.), Par Sterile Products, LLC (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Azevan Pharmaceuticals, Inc. (U.S.), Taj Pharmaceuticals Limited (India), Otsuka Holdings Co. Ltd (Japan), and ALLERGAN (U.S.).
What are the types included in the Antidiuretic Drugs Market?
The indications discussed are hypertension, hemophilia, diabetes insipidus, and others.
1 Report Prologue
2 Market Introduction
2.2 Scope of the Study
2.2.1 Research Objective
3 Research Methodology
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation
4 Market Dynamics
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
5. Market Factor Analysis
5.1 Porters five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain
5.3 Investment Feasibility Analysis
5.4 Price Factor Analysis
6 Global Antidiuretic drugs Market, by Type
7 Global Antidiuretic drugs Market, by Indication
7.2 Diabetes Insipidus
7.2.1 Central Diabetes Insipidus
7.2.2 Nephrogenic Diabetes Insipidus
7.2.3 Dipsogenic Diabetes Insipidus
7.2.3 Gestational Diabetes Insipidus
8 Global Antidiuretic drugs Market, by End User
8.4 Pharmaceutical Companies
9 Global Antidiuretic drugs Market by Region
9.2.1 North America
9.2.2 Latin America
9.3.1 Western Europe
18.104.22.168 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia Pacific
9.4.4 Republic of Korea
9.4.6 Rest of Asia Pacific
9.5 Middle East & Africa
9.5.1 United Arab Emirates
9.5.2 Saudi Arabia
9.5.6 Rest of Middle East & Africa
10 Company Landscape
10.2 Market share Analysis
10.3 Key Development & Strategies
10.3.1 Key Developments
11 Company Profiles
11.1 Par Sterile Products, LLC
11.1.1 Company Overview
11.1.2 Product Overview
11.1.4 SWOT Analysis
11.2 Azevan Pharmaceuticals, Inc.
11.2.1 Company Overview
11.2.2 Product Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 Teva Pharmaceutical Industries Ltd.
11.3.1 Company Overview
11.3.2 Product Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 Taj Pharmaceuticals Limited
11.4.1 Company Overview
11.4.2 Product/Business Segment Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5.1 Company Overview
11.5.2 Product Overview
11.5.3 Financial overview
11.5.4 Key Developments
11.6 Otsuka Holdings Co. Ltd
11.6.1 Company Overview
11.6.2 Product Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.7 ADH Health
11.7.2 Product Overview
11.7.4 Key Developments
11.7.5 SWOT Analysis
12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEO’s View Point
12.1.2 Unmet Needs of the Market
12.2 Key Companies to Watch
12.3 Prediction of Healthcare Industry